ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Prepaid Assets of $3.6 million for Q1 2026, up 9.21% year-on-year from $3.3 million in Q1 2025, and up 20.97% on a QoQ basis from $3.0 million in Q4 2025.
ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Prepaid Assets for 14 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 9.21% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 9.21% YoY) and the FY2025 annual result came in at $3.0 million, up 9.0% from the prior year.
- Prepaid Assets climbed to $3.6 million in Q1 2026 per PRQR's latest filing, from $3.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for PRQR reached as high as $4.7 million in Q2 2022 and fell as low as $902397.7 in Q4 2023.
- A 5-year average of $2.8 million and a median of $2.7 million in 2024 frame the typical range for Prepaid Assets.
- The largest YoY upside for Prepaid Assets was 89158.93% in 2022 against a maximum downside of 84.79% in 2022.
- Year by year, Prepaid Assets stood at $2.8 million in 2022, then tumbled by 67.62% to $902397.7 in 2023, then jumped by 203.91% to $2.7 million in 2024, then gained by 9.0% to $3.0 million in 2025, then rose by 20.97% to $3.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.6 million, $3.0 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 902,397.74 |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 4.73 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 23.22 Mn |
| Jun 30, 2021 | 4.28 Mn |